SEOUL, May 3 (Korea Bizwire) — South Korean drug and biotechnology companies are speeding up efforts to explore new growth engines to cope with the shift of COVID-19 from pandemic to endemic. Pharmaceutical giant Celltrion Inc. aims to launch its autoimmune disease biosimilar Yuflyma in the United States this year. It also made an equity [...]
SEOUL, April 27 (Korea Bizwire) — South Korean pharmaceutical giant Celltrion Inc. said Wednesday it will begin sales of its autoimmune disease biosimilar Yuflymain in the United States in July 2023. The plan comes as Celltrion has settled a patent dispute with U.S. drugmaker AbbVie Inc. Yuflyma — a biosimilar referencing blockbuster drug Humira — [...]
SEOUL, April 26 (Korea Bizwire) — South Korea has developed a new molecular diagnosis technology that can detect not only COVID-19 but also other future viruses in a rapid and accurate manner. The National Research Foundation of Korea said Monday that researchers at Konkuk University had succeeded in developing a molecular diagnosis procedure that can [...]
SEOUL, April 22 (Korea Bizwire) — SD Biosensor Inc., a South Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won (US$49.8 million) in an effort to tap deeper into the European market. The contract calls for SD Biosensor to acquire [...]
SEOUL, April 21 (Korea Bizwire) – The number of obese people in South Korea more than doubled between 2017 and 2021, a trend exacerbated by the coronavirus pandemic, data showed Thursday. According to the Health Insurance Review and Assessment Service, the number of overweight patients increased from 14,966 in 2017 to 31,170 last year. The [...]
SEOUL, April 20 (Korea Bizwire) — Samsung Biologics Co., the biotech arm of South Korea’s Samsung Group, said Wednesday it has completed the first payment to acquire the U.S. drugmaker’s entire stake in Samsung Bioepis. Earlier, Samsung Biologics reached a deal with Biogen to purchase the U.S. drugmaker’s entire stake in Samsung Bioepis for US$2.3 [...]
SEOUL, April 20 (Korea Bizwire) — The Seoul Metropolitan Government said Tuesday it will begin studies to provide a healthy environment for rearing toddlers born during the pandemic era and growing up in the post-pandemic era. The city government first signed an agreement with the Korean Academy of Child and Adolescent Psychiatry to organize a [...]
SEOUL, April 14 (Korea Bizwire) — The South Korean unit of U.S. pharmaceutical giant Pfizer Inc. chalked up massive sales last year thanks to special demand for COVID-19 vaccines, but sent most of its income to its head office. According to the Financial Supervisory Service, Pfizer Pharmaceuticals Korea Ltd. chalked up revenue of 1.69 trillion [...]
SEOUL, April 13 (Korea Bizwire) — Depression takes a toll on heart conditions, a recent study revealed. A joint research team from Korea University Anam Hospital and Soongsil University studied 10-year data on 5 million South Korean adults who turned out to have no heart-related health issues in their national health exams taken between 2002 [...]
SEOUL, April 12 (Korea Bizwire) — Seniors with a spouse suffering from dementia are more likely to be diagnosed with dementia themselves, a study showed Monday. A research team from Seoul National University Bundang Hospital conducted a survey of 784 senior couples in the country who are over 60 years of age every two years [...]